|
|
|
|
|
|
|
|
|
ARTICLE 1
DEFINITIONS
|
|
|
1
|
|
|
|
|
Definitions
|
|
|
1
|
|
|
ARTICLE 2
PURCHASE AND SALE
|
|
|
8
|
|
|
|
|
Purchase and
Sale
|
|
|
8
|
|
|
|
|
Assets Not to
be Transferred
|
|
|
9
|
|
|
|
|
Liabilities and
Obligations
|
|
|
10
|
|
|
|
|
Purchase
Price
|
|
|
10
|
|
|
|
|
Transfer
Taxes
|
|
|
10
|
|
|
ARTICLE 3
CLOSING
|
|
|
11
|
|
|
|
|
The
Closing
|
|
|
11
|
|
|
ARTICLE 4
REPRESENTATIONS AND WARRANTIES OF SELLER
|
|
|
12
|
|
|
|
|
Organization of
Seller
|
|
|
12
|
|
|
|
|
Authorization
|
|
|
12
|
|
|
|
|
Taxes
|
|
|
13
|
|
|
|
|
Condition and
Sufficiency of Assets
|
|
|
15
|
|
|
|
|
Governmental
Permits
|
|
|
15
|
|
|
|
|
Title to
Purchased Assets
|
|
|
15
|
|
|
|
|
Intellectual
Property
|
|
|
15
|
|
|
|
|
Accounts
Receivable and Inventory
|
|
|
17
|
|
|
|
|
Contracts
|
|
|
17
|
|
|
|
|
No Violation,
Litigation or Regulatory Action
|
|
|
18
|
|
|
|
|
Environmental
Matters
|
|
|
18
|
|
|
|
|
No
Finder
|
|
|
19
|
|
|
|
|
Customers and
Suppliers
|
|
|
19
|
|
|
|
|
Seller
Financial Statements
|
|
|
19
|
|
|
|
|
No
Changes
|
|
|
19
|
|
|
|
|
Insurance
|
|
|
21
|
|
|
|
|
FDA
Matters
|
|
|
21
|
|
|
|
|
Products;
Product Liability
|
|
|
23
|
|
|
|
|
Investment
Representations
|
|
|
23
|
|
|
|
|
Capital
Expenditures
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclosure
|
|
|
24
|
|
|
|
|
Net Working
Capital Certificate
|
|
|
24
|
|
|
ARTICLE 5
REPRESENTATIONS AND WARRANTIES OF BUYER
|
|
|
24
|
|
|
|
|
Organization of
Buyer
|
|
|
24
|
|
|
|
|
Authorization
|
|
|
24
|
|
|
|
|
Non-Contravention; Consents
|
|
|
25
|
|
|
|
|
Validity of
Shares
|
|
|
25
|
|
|
|
|
No
Finder
|
|
|
25
|
|
|
ARTICLE 6
ADDITIONAL AGREEMENTS
|
|
|
25
|
|
|
|
|
Taxes
|
|
|
25
|
|
|
|
|
Noncompetition
Agreement
|
|
|
26
|
|
|
|
|
Use of
Name
|
|
|
26
|
|
|
|
|
Restrictions on
Securities
|
|
|
26
|
|
|
|
|
Registration
|
|
|
27
|
|
|
|
|
Cash
Adjustments Based on Effectiveness Price
|
|
|
28
|
|
|
|
|
Transition
Covenant
|
|
|
28
|
|
|
|
|
Non-Disparagement
|
|
|
28
|
|
|
|
|
Right to Use
Name
|
|
|
28
|
|
|
|
|
Recourse
Against MBI
|
|
|
28
|
|
|
ARTICLE 7
CONDITIONS PRECEDENT TO OBLIGATIONS OF BUYER
|
|
|
29
|
|
|
|
|
No
Misrepresentation or Breach of Covenants and Warranties
|
|
|
29
|
|
|
|
|
No Restraint or
Litigation
|
|
|
29
|
|
|
|
|
Necessary
Governmental Approvals
|
|
|
29
|
|
|
|
|
Necessary
Consents
|
|
|
29
|
|
|
|
|
Additional
Agreements
|
|
|
29
|
|
|
|
|
Manager
Agreements
|
|
|
29
|
|
|
|
|
No Material
Adverse Event
|
|
|
29
|
|
|
|
|
Receipt of
Closing Deliveries
|
|
|
29
|
|
|
|
|
Supply
Agreement Amendment
|
|
|
30
|
|
|
ARTICLE 8
CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER
|
|
|
30
|
|
|
|
|
No
Misrepresentation or Breach of Covenants and Warranties
|
|
|
30
|
|
|
|
|
No Restraint or
Litigation
|
|
|
30
|
|
|
|
|
Necessary
Governmental Approvals
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
Agreements
|
|
|
30
|
|
|
ARTICLE 9
INDEMNIFICATION
|
|
|
30
|
|
|
|
|
Grant of
Indemnity
|
|
|
30
|
|
|
|
|
Representation,
Cooperation and Settlement
|
|
|
32
|
|
|
|
|
Interest
|
|
|
33
|
|
|
|
|
Survival of
Representations and Warranties
|
|
|
33
|
|
|
|
|
Indemnity
Cap
|
|
|
33
|
|
|
|
|
Sole and
Exclusive Remedy
|
|
|
33
|
|
|
|
|
Thresholds
|
|
|
33
|
|
|
ARTICLE 10
GENERAL PROVISIONS
|
|
|
34
|
|
|
|
|
Survival of
Obligations
|
|
|
34
|
|
|
|
|
Confidentiality
|
|
|
34
|
|
|
|
|
No Public
Announcements
|
|
|
34
|
|
|
|
|
Notices
|
|
|
34
|
|
|
|
|
Successors and
Assigns
|
|
|
35
|
|
|
|
|
Access to
Records after Closing Date
|
|
|
35
|
|
|
|
|
Entire
Agreement; Amendments
|
|
|
35
|
|
|
|
|
Interpretation
|
|
|
35
|
|
|
|
|
Waivers
|
|
|
36
|
|
|
|
|
Expenses
|
|
|
36
|
|
|
|
|
Partial
Invalidity
|
|
|
36
|
|
|
|
|
Execution in
Counterparts
|
|
|
36
|
|
|
|
|
Further
Assurances
|
|
|
36
|
|
|
|
|
Governing
Law
|
|
|
37
|
|
|
|
|
Dispute
Resolution
|
|
|
37
|
|
|
|
|
Effect of Due
Diligence
|
|
|
37
|
|
|
|
|
No Third-Party
Beneficiaries
|
|
|
37
|
|
|
|
|
Attorneys’ Fees
|
|
|
37
|
|
This ASSET
PURCHASE AGREEMENT (the “ Agreement ”), dated as
of January 23, 2007, is entered into by and among NuVasive,
Inc., a Delaware corporation (“ Buyer ”), Radius
Medical, LLC, a California limited liability company (“
Seller ”), and, with respect to Section 6.7, 6.8
and Article 9 hereof only, Biologic, LLC, a California limited
liability company (“ Biologic ”), Antone Family
Partners, a California general partnership (“ Antone
Partners ”), and Russell Cook and Duraid Antone, each
individual residents of the state of California (each, a “
Manager ,” and collectively, the “
Managers ”).
WHEREAS, Seller
owns certain assets in connection with the design, development,
marketing and distribution by Seller of the Products (collectively,
the “ Business ”); and
WHEREAS, subject
to the terms and conditions of this Agreement, Seller desires to
sell, and Buyer desires to buy, all of Seller’s right, title
and interest in and to substantially all of the assets used in or
necessary for the operation of the Business, except the Excluded
Assets as hereinafter defined;
NOW, THEREFORE, in
consideration of the premises and the covenants and representations
set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the
parties hereto hereby agree as follows:
1.1
Definitions . In this Agreement, the following terms have
the meanings specified or referred to in this Section 1.1 and
shall be equally applicable to both the singular and plural forms.
Any agreement referred to below shall mean such agreement as
amended, supplemented and modified from time to time to the extent
permitted by the applicable provisions thereof and by this
Agreement.
“
Accounts Receivable ” has the meaning specified in
Section 4.8(a) hereof.
“
Additional Agreements ” means all agreements
(including exhibits), instruments and documents being or to be
executed and delivered under this Agreement or in connection
herewith, including, but not limited to the following: (i) the
Assignment and Assumption Agreement; (ii) the Assignment of
Patents; (iii) the Assignment of Copyrights; (iv) the
Assignment of Trademarks; (v) the Bill of Sale; (vi) the
Assignment and Assumption of Contracts; (vii) the Escrow
Agreement; and (viii) the Manager Agreements, each in the form
attached as an exhibit hereto.
“
Additional Consideration ” has the meaning specified
in Section 2.4(b) hereof.
“
Additional Payment Date ” has the meaning specified in
Section 2.4(b) hereof.
“
Affiliate ” means, as to any Person, any other Person
which is controlling, controlled by or under common control with
such Person.
“ Antone
Partners ” has the meaning specified in the first
paragraph of this Agreement.
“
Assignment and Assumption Agreement ” means that
certain Assignment and Assumption Agreement dated as of the Closing
Date, by and between Buyer and Seller, in substantially the form
attached hereto as Exhibit A .
“
Assignment and Assumption of Contracts ” means that
certain Assignment and Assumption of Contracts dated as of the
Closing Date, by and between Buyer and Seller, in substantially the
form attached hereto as Exhibit B .
“
Assignment of Copyrights ” means that certain
Assignment of Copyrights dated as of the Closing Date, by and
between Buyer and Seller, in substantially the form attached hereto
as Exhibit C .
“
Assignment of Patents ” means that certain Assignment
of Patents dated as of the Closing Date, by and between Buyer and
Seller, in substantially the form attached hereto as
Exhibit D .
“
Assignment of Trademarks ” means that certain
Assignment of Trademarks dated as of the Closing Date, by and
between Buyer and Seller, in substantially the form attached hereto
as Exhibit E .
“ Assumed
Liabilities ” has the meaning specified in
Section 2.3(a) hereof.
“ Balance
Sheet ” has the meaning specified in Section 4.14
hereof.
“ Bill of
Sale ” means that certain Bill of Sale dated as of the
Closing Date, by and between Buyer and Seller, relating to the sale
of certain of the Purchased Assets, in substantially the form
attached hereto as Exhibit F .
“
Biologic ” has the meaning specified in the first
paragraph of this Agreement.
“
Business ” has the meaning specified in the recitals
to this Agreement.
“
Buyer ” has the meaning specified in the first
paragraph of this Agreement.
“ Buyer
Affiliates ” has the meaning specified in
Section 9.1(a) hereof.
“
Buyer’s Damages ” has the meaning specified in
Section 9.1(a) hereof.
“ Cash
Consideration ” has the meaning specified in
Section 2.4(a)(i) hereof.
“
CERCLA ” means the Comprehensive Environmental
Response, Compensation and Liability Act of 1980, as
amended.
“ Claims
and Losses ” has the meaning specified in
Section 9.1(a) hereof.
2
“
Closing ” has the meaning specified in
Section 3.1 hereof.
“ Closing
Date ” has the meaning specified in Section 3.1
hereof.
“ Closing
Price ” means the Reference Market Value on the Closing
Date (as adjusted for stock splits, stock dividends,
reclassifications or similar events).
“
Code ” means the United States Internal Revenue Code
of 1986, as amended.
“ Common
Stock ” means the Common Stock of Buyer, $0.001 par value
per share.
“
Competitive Activity ” means directly or indirectly
(or having any material interest in a Person) (i) engaging in
any activity that is the same as, materially similar to, or
competitive with the Business; (ii) engaging in the
development or distribution of any product that is the same as,
materially similar to, or competitive with any of the Products
developed or sold by Buyer during the Noncompetition Period; or
(iii) diverting or attempting to divert from Buyer or any
Affiliate of Buyer any business of any kind relating to the
Business, including the solicitation of or interference with any
suppliers, consultants, contractors, or customers of such
operations; provided, however, that the development or distribution
of a product that does not have a principal application in spinal
surgery shall not be deemed a Competitive Activity.
“
Contracts ” has the meaning specified in
Section 4.9 hereof.
“
Effectiveness Date ” means the date that the
Registration Statement to be filed pursuant to Section 6.5 is
first declared effective by the SEC.
“
Effectiveness Price ” means the Reference Market Value
on the Effectiveness Date (as adjusted for stock splits, stock
dividends, reclassifications or similar events).
“
Encumbrance ” means any lien, claim, charge, security
interest, mortgage, pledge, easement, conditional sale or other
title retention agreement, defect in title, covenant or other
restrictions of any kind.
“
Environmental and Safety Requirements ” means all
federal, state, local and foreign statutes, regulations, ordinances
and other provisions having the force or effect of law, all
judicial and administrative orders and determinations, all
contractual obligations and all common law, in each case concerning
public health and safety, worker health and safety and pollution or
protection of the environment (including, without limitation, all
those relating to the presence, use, production, generation,
handling, transport, treatment, storage, disposal, distribution,
labeling, testing, processing, discharge, Release, threatened
Release, control or cleanup of any hazardous or otherwise regulated
materials, substances or wastes, chemical substances or mixtures,
pesticides, pollutants, contaminants, toxic chemicals, petroleum
products or byproducts, asbestos, polychlorinated biphenyls, noise,
radiation or radon), each as amended and. as now or hereafter in
effect.
“
Environmental Lien ” means any lien, whether recorded
or unrecorded, in favor of any governmental entity, relating to any
liability of Seller arising under any Environmental and Safety
Requirements.
3
“ Escrow
Agent ” shall mean Wells Fargo Bank, National
Association.
“ Escrow
Agreement ” means that certain Escrow Agreement dated as
of the Closing Date, by and between Buyer, Seller and the Escrow
Agent, in substantially the form attached hereto as
Exhibit I .
“
Exchange Act ” means the Securities Exchange Act of
1934, as amended.
“
Excluded Assets ” has the meaning specified in
Section 2.2 hereof.
“ FDA
” means the United States Food and Drug
Administration.
“
Financials ” has the meaning specified in
Section 4.14 hereof.
“
510(k) ” has the meaning specified in
Section 4.17(d) hereof.
“
GAAP ” means the United States generally accepted
accounting principles.
“
Governmental Body ” means any foreign, federal, state,
county, local, district, public authority, public agency or any
other political subdivision, public corporation or governmental or
regulatory authority, whether foreign or domestic.
“
Governmental Order ” means any judgment, order, award
or decree of any foreign, federal, state, local or other court or
tribunal, or any Governmental Body and any award in any arbitration
proceeding.
“
Governmental Permits ” has the meaning specified in
Section 4.5(a) hereof.
“ IDE
” has the meaning specified in Section 4.17(d)
hereof.
“
Indebtedness ” means, with respect to any Person, any
indebtedness, secured or unsecured, (a) in respect of borrowed
money (whether or not the recourse of the lender is to the whole of
the assets of such Person or only to a portion thereof), and
evidenced by bonds, notes, debentures or similar instruments or
letters of credit, to the extent of the face value thereof (or, in
the case of evidence of indebtedness issued at a discount, the
current accredit value thereof) or (b) representing the
balance deferred and unpaid of the purchase price of property or
services (other than accounts payable (including trade payables) in
the ordinary course of business) and shall also include, to the
extent not otherwise included, (i) any capitalized lease
obligations and (ii) the face value of guaranties of items of
other Persons which would be included within this definition for
such other Persons (whether or not such items would appear upon the
balance sheet of the guarantor).
“
Indemnified Party ” has the meaning specified in
Section 9.2(b) hereof.
“
Indemnifying Party ” has the meaning specified in
Section 9.2(b) hereof.
“
Intellectual Property ” means all of the intellectual
property used in the Business or Products, including:
(a) inventions, whether or not patentable, whether or not
reduced to practice,
4
and whether or
not yet made the subject of a pending patent application or
applications; (b) ideas and conceptions of potentially
patentable subject matter, including without limitation, any patent
disclosures, whether or not reduced to practice and whether or not
yet made the subject of a pending patent application or
applications; (c) all worldwide statutory invention
registrations, patents, patent registrations and patent
applications (including all reissues, divisions, continuations,
continuations-in-part, extensions and reexaminations) and all
rights therein provided by law, multinational treaties or
conventions and all improvements to the inventions disclosed in
each such registration, patent or application (collectively,
“ Patents ”); (d) trademarks, service marks,
trade dress, logos, limited liability company names and trade
names, including all of the goodwill associated therewith, whether
or not registered, including all common law rights and
registrations and applications for registration thereof
(collectively, “ Trademarks ”);
(e) copyrights, whether or not registered, and registrations
and applications for registration thereof, and all rights therein
provided by law, multinational treaties or conventions
(collectively, “ Copyrights ”); (f) trade
secrets and confidential, technical information (including ideas,
formulas, compositions, inventions and conceptions of inventions,
whether patentable or unpatentable and whether or not reduced to
practice) (collectively, “ Trade Secrets ”);
(g) technology (including know-how and show-how),
manufacturing and production processes and techniques, research and
development information, drawings, specifications, designs, plans,
proposals, technical data and copyrightable works, whether secret
or confidential or not; (h) copies and all tangible
embodiments of all of the foregoing, in whatever form or medium;
(i) all rights to obtain and rights to apply for patents, and
to register trademarks and copyrights; (j) all rights to sue
for and recover and retain damages, costs or attorneys’ fees
for present and past infringement of any of the Intellectual
Property rights described above; (k) any non-infringement
and/or invalidity opinions received by Seller with respect to any
of the Intellectual Property rights described above; and
(l) the names used and associated with any of the
Products.
“ Interim
Financial Statements ” has the meaning specified in
Section 4.14 hereof.
“
Inventory ” has the meaning specified in
Section 4.8(b) hereof.
“ IRS
” means the Internal Revenue Service of the United States of
America.
“
Manager(s) ” has the meaning specified in the first
paragraph of this Agreement.
“ Manager
Agreements ” means those certain Consulting and
Non-Competition Agreements dated as of the Closing Date, by and
between Buyer and each of the Managers, each in substantially the
form attached hereto as Exhibit G .
“
Material Adverse Event ” means any change,
circumstance or effect that, individually or in the aggregate with
all other changes, circumstances and effects, is or would be
reasonably likely to have a material adverse effect on (i) the
Purchased Assets, or (ii) the Business.
“ MBI
” means Maxigen Biotech, Inc., an entity organized under the
laws of Taiwan, and any successor thereto.
“
Member(s) ” means, individually, Biologic and Antone
Partners, and collectively, Biologic and Antone
Partners.
5
“ Net
Sales ” means the total amount of gross receipts of Buyer
in connection with sales of Products to non-Affiliate third parties
less deduction of all of the following to the extent applicable to
such sales: (a) all trade and quantity credits, discounts,
charge backs from wholesalers, refunds or rebates which are
actually allowed and taken; (b) all amounts of insurance and
freight expenses included in any invoice; (c) all allowances
or credits for returns or rejected products to the extent such
amounts are included in the original gross receipts; and
(d) all sales taxes (including value added taxes), duties or
other governmental charges incurred.
“ Net
Working Capital ” means (A) Seller’s
consolidated total current assets (as defined by and determined in
accordance with GAAP) to be transferred to Buyer as of the Closing
Date less (B) Seller’s consolidated total current
liabilities (as defined by and determined in accordance with GAAP)
to be transferred to Buyer as of the Closing Date. For purposes of
calculating Net Working Capital, Seller’s current liabilities
shall include all indebtedness being assumed by Buyer whether or
not such indebtedness would be treated as a current liability under
GAAP.
“ Net
Working Capital Certificate ” means a certificate
executed by the Managers dated as of the Closing Date, certifying
the amount of Net Working Capital (including (i) an itemized
list of each element of Seller’s consolidated current assets
being transferred to Buyer, (ii) an itemized list of each
element of Seller’s consolidated current liabilities being
transferred to Buyer, and (iii) any other supporting
documentation, information and calculations as are, in
Seller’s good faith reasonable judgment, necessary for Buyer
to verify and determine the amount of the Net Working Capital and
indebtedness).
“ Net
Working Capital Threshold ” means $250,000.
“
Noncompetition Period ” has the meaning specified in
Section 6.2 hereof.
“
Nondisclosure Agreement ” means that certain Mutual
Non-Disclosure and Non-Use Agreement, dated as of July 31,
2006, by and between Buyer and Seller.
“
Permitted Encumbrances ” means (a) liens for
taxes and other governmental charges and assessments which are not
yet due and payable, (b) liens of landlords and liens of
carriers, warehousemen, mechanics and materialmen and other like
liens arising in the ordinary course of business for sums not yet
due and payable and (c) other liens or imperfections on
property which are not material in amount or do not materially
detract from the value of or materially impair the existing use of
the property affected by such lien or imperfection.
“
Person ” means any individual, corporation,
partnership, limited liability company, joint venture, association,
joint stock company, trust, unincorporated organization,
Governmental Body or any other entity.
“
Products ” means any collagen-based medical
biomaterials products or any other products designed, developed,
manufactured or marketed by Buyer or Seller that incorporate the
Patents or Intellectual Property, including without limitation,
(i) the synthetic bone graft substitute consisting of
resorbable purified fibrillar collagen and partially or fully
resorbable hydroxyapatite and/or tricalcium phosphate ceramics
marketed and distributed by Seller under the name Formagraft, and
(ii) a bone marrow aspiration needle.
6
“
Purchase Price ” has the meaning specified in
Section 2.4 hereof.
“
Purchased Assets ” has the meaning specified in
Section 2.1 hereof.
“
Records ” has the meaning specified in
Section 2.1(a)(vii) hereof.
“
Reference Market Value ” means the average closing
sale price, as published in the Wall Street Journal, of a share of
Common Stock on the Nasdaq Global Market for the ten (10)
consecutive trading day period ending three (3) business days
prior to the date on which such Reference Market Value is
determined.
“
Registration Statement ” has the meaning specified in
Section 6.5(a) hereof.
“
Release ” has the meaning specified in
CERCLA.
“
Requirements of Laws ” means any applicable foreign,
federal, state and local laws, statutes, regulations, rules, codes,
ordinances, enforceable judgments, injunctions, decrees and orders,
permits, approvals, treaties, enacted, adopted, issued or
promulgated by any Governmental Body (including, without
limitation, those pertaining to electrical, building, zoning,
environmental and occupational safety and health requirements) or
common law in effect as of the Closing Date.
“
Restricted Territory ” means North America (the United
States, Canada and Mexico), EU countries, South America and Central
America countries, Australia and New Zealand, and each of their
respective territories.
“
Retained Liabilities ” has the meaning specified in
Section 2.3(b) hereof.
“
Schedules ” has the meaning specified in the
introductory paragraph to Article 4 hereof.
“ SEC
” means the United States Securities and Exchange
Commission.
“
Securities Act ” means the United States Securities
Act of 1933, as amended.
“
Seller ” has the meaning specified in the first
paragraph of this Agreement.
“ Seller
Affiliates ” has the meaning specified in
Section 9.1(b) hereof.
“ Seller
Damages ” has the meaning specified in
Section 9.1(b) hereof.
“
Shares ” has the meaning specified in
Section 2.4(a)(ii) hereof.
“ Share
Consideration ” has the meaning specified in
Section 2.4(a)(ii) hereof.
“ Supply
Agreement ” means that certain Supply Agreement, dated
November 4, 2004, as amended, between Seller and
MBI.
“ Supply
Agreement Amendment ” means an amendment to the Supply
Agreement, to be dated on or before the Closing Date, and to be
entered into by and among Seller and MBI.
7
“ Tax
” means any federal, state, local or foreign net income,
alternative or add-on minimum, gross income, gross receipts,
property, sales, use, transfer, gains, license, excise, employment,
payroll, withholding or minimum tax, or any other tax custom, duty,
governmental fee or other like assessment or charge of any kind
whatsoever, together with any interest or any penalty, addition to
tax or additional amount imposed by any Governmental
Body.
“ Tax
Return ” means any return, report or similar statement
required to be filed with respect to any Taxes (including any
attached schedules), including, without limitation, any information
return, claim for refund, amended return and declaration of
estimated Tax.
“ Third
Party Expenses ” has the meaning specified in
Section 10.10 hereof.
“
Transfer Taxes ” has the meaning specified in
Section 2.5 hereof.
“
Transferred Agreements ” has the meaning specified in
Section 2.1(a)(viii) hereof.
“
Transferred Permits ” has the meaning specified in
Section 2.1(a)(ix) hereof.
“
Transition Activities ” means the activities and
obligations set forth on Schedule 6.7 hereto.
“ 2005
Financial Statements ” has the meaning specified in
Section 4.14 hereof.
“ Unpaid
Indemnification Claims ” has the meaning specified in
Section 2.4(b) hereof.
(a) On
the terms and subject to the conditions of this Agreement, at the
Closing, Seller shall sell, convey, assign and transfer to Buyer,
and Buyer shall purchase from Seller, all right, title and interest
of Seller in and to substantially all of the tangible and
intangible properties and assets owned or held by Seller and
relating to or used, or held for use, in connection with the
Business (collectively, the “ Purchased Assets
”) free and clear of all Encumbrances (except for Permitted
Encumbrances), but excluding the Excluded Assets (as defined in
Section 2.2), such Purchased Assets to include, but not be
limited to:
(i) all
Inventory set forth on Schedule 4.8(b)
hereto;
(ii) all
packaging and labeling equipment and materials set forth on
Schedule 2.1(a)(ii) hereto;
(iii) all
license agreements related to the Purchased Assets and the
Business, including without limitation, past and current licenses
and licenses relating to all Products;
8
(iv) the
goodwill and going concern value of the Business;
(v) all
Intellectual Property;
(vi) the
names of the Products and any similar sounding names and variants
thereof and any other names used by Seller in the sales and
marketing materials or on the Products, however labeled, which
shall expressly include the right of Buyer to market, distribute
and sell any existing Products or existing Inventory bearing any
corporate names or variants thereof of Seller;
(vii) all
existing supplier lists, customer lists, pricing lists, records,
books, ledgers, files, documents, correspondence, repair and
maintenance records, operation manuals, advertising, promotional
and marketing materials (including, without limitation, catalogues,
brochures, trade show equipment, field inventory, loaners, sales
force inventory and consignments), studies and reports related
primarily to the Purchased Assets or the Business and complete and
accurate copies of all applications, registrations, agreements and
other documents referenced on Schedule 4.7(a) hereto
(collectively, the “ Records ”);
(viii) all
contracts, agreements, commitments, licenses, undertakings,
arrangements, and other legally binding contractual rights or
obligations to which Seller is a party and which are listed on
Schedule 2.1(a)(viii) hereto (collectively, the “
Transferred Agreements ”), including, without
limitation, the rights contained in the Supply
Agreement;
(ix) all
licenses, permits, approvals, clearances, variances, waivers or
consents issued by any Governmental Body used in or necessary to
the operation of the Business (collectively, the “
Transferred Permits ”), to the extent
transferable;
(x) all
prepaid expenses, advance payments, deposits, surety accounts and
other similar assets related to the Business, including without
limitation, prepaid deposits with suppliers;
(xi) all
rights, claims and benefits of Seller in, to or under, any (i)
(A) employee confidentiality agreements entered into by Seller
and (B) confidentiality or secrecy agreements entered into by
Seller with third parties that relate to the use or disclosure of
information concerning the Purchased Assets or the Business, and
(ii) express or implied warranties from the suppliers of goods
or services (including any coverage rights under product liability
or other insurance maintained by any of such suppliers for the
benefit of Seller);
(xii) any
unfilled purchase and sale orders of Seller related to the
Business; and
(xiii) all
other assets, properties and rights of Seller of every kind
associated with the Business, whether tangible or intangible, and
wherever situated, including without limitation, Seller’s
books and records, other than the Excluded Assets.
2.2 Assets Not
to be Transferred . Seller shall retain and Buyer shall not
acquire (i) any Accounts Receivable or (ii) all of the
assets, properties and rights, if any, set forth on
Schedule 2.2(b) hereto, which together shall constitute
the “ Excluded Assets .”
9
2.3 Liabilities
and Obligations .
(a) On
the Closing Date, Buyer shall accept, assume and agree to pay,
perform or otherwise discharge, in accordance with the respective
terms and subject to the respective conditions thereof and hereof,
all those liabilities set forth on Schedule 2.3 (the
“ Assumed Liabilities ”). Notwithstanding the
fact that obligations under the Transferred Agreements are included
on Schedule 2.3 , except as expressly set forth on such
Schedule, Buyer is only assuming the obligation to perform
Seller’s obligations under such Transferred Agreements after
the Closing Date, and nothing contained herein shall have the
effect of causing Buyer to have assumed or be responsible for any
obligations that arose under such Transferred Agreements prior to
or on the Closing Date regardless of whether such pre-Closing Date
obligations arose in the ordinary course or as a result of any
breach or default by Seller.
(b) Except
as expressly set forth in Section 2.3(a) above, Buyer shall
not assume or have any responsibility for any liability, obligation
or commitment of any nature of Seller prior to the Closing, whether
now or hereafter existing, known or unknown, accrued or unaccrued
or due to come due, including, without limitation, those
liabilities and obligations specifically identified as
“Retained Liabilities” throughout this Agreement
(herein collectively, the “ Retained Liabilities
”). Seller acknowledges and agrees that it shall be fully
responsible for all such Retained Liabilities. The parties agree
that notwithstanding the disclosure of a liability on a Schedule
hereto (other than Schedule 2.3 ), such liability shall
constitute a Retained Liability unless it is explicitly set forth
on Schedule 2.3 .
(a) In
consideration for the Purchased Assets, Buyer shall pay or do the
following (collectively referred to as the “ Purchase
Price ”):
(i) Buyer
shall pay to Seller at Closing $5,800,000 less the amount by
which Net Working Capital is less than the Net Working Capital
Threshold at the Closing by wire transfer of immediately available
funds to such account as Seller shall, not less than three
(3) business days prior to the Closing Date, designate in
writing to Buyer (the “ Cash Consideration ”);
and
(ii) Buyer
shall issue to Seller at Closing that number of shares of Common
Stock (the “ Shares ”) equal to the quotient
obtained by dividing $10,200,000 (the “ Share
Consideration ”) by the then applicable Reference Market
Value on the Closing Date.
(b) At
the Closing buyer shall deposit with the Escrow Agent $2,000,000
(the “ Additional Consideration ”) to be held in
escrow to secure any and all Claims and Losses suffered or incurred
by Buyer or any Buyer Affiliates during the 18 month period
following the Closing for which Buyer or such Buyer Affiliates are
entitled to indemnification pursuant to Article 9 of this
Agreement and in respect of which Buyer and such Buyer Affiliates
have not been actually indemnified by Seller, the Members or the
Managers (“ Unpaid Indemnification Claims
”).
2.5 Transfer
Taxes . All use, value-added, gross receipts, excise,
registration, stamp duty, sales, transfer or other similar taxes or
governmental fees (“ Transfer Taxes ”)
imposed,
10
levied or
payable by reason of the signing of this Agreement and by reason of
the transfer of assets and assumption of liabilities contemplated
hereby shall be paid by Buyer. Seller shall cooperate with Buyer to
the extent reasonably requested and legally permitted to minimize
any Transfer Taxes.
(a) The
consummation of the transactions contemplated by this Agreement
shall be consummated (the “ Closing ”) at the
offices of Heller Ehrman LLP in San Diego, California on
January 23, 2007, or such other place, time and date as the
parties shall agree in writing. The time and date on which the
Closing is actually held is referred to herein as the “
Closing Date .”
(b) Subject
to fulfillment or waiver of the conditions set forth in
Article 7, at the Closing, Buyer shall deliver to Seller each
of the following:
(i) the
Cash Consideration;
(ii) a
certificate representing the Shares;
(iii) the
certificate contemplated by Section 8.1 below, duly executed
by an authorized officer of Buyer; and
(iv) the
Additional Agreements duly executed by Buyer.
(c) Subject
to fulfillment or waiver of the conditions set forth in
Article 8, at the Closing, Seller shall deliver to Buyer each
of the following:
(i) certificates
of title or origin (or like documents) with respect to any asset
included in the Purchased Assets for which a certificate of title
or origin is required in order to transfer title;
(ii) all
consents, waivers or approvals listed on Schedule 4.2
hereto;
(iii) the
certificate contemplated by Section 7.1 below, duly executed
by the Managers;
(iv) certified
copies of the resolutions duly adopted by the Members authorizing
the execution, delivery and performance of this Agreement and the
Additional Agreements and the consummation of the transactions
contemplated hereby and thereby;
(v) good
standing certificates for Seller from the Secretary of State of the
State of California dated not more than ten (10) days prior to
the Closing Date;
11
(vi) the
legal opinion of Rutan & Tucker, LLP, counsel to Seller,
substantially in the form attached hereto as Exhibit H
;
(vii) releases,
including without limitation, termination statements under the
Uniform Commercial Code of any financing statements filed against
any of the Purchased Assets, evidencing discharge, removal and
termination of all Encumbrances to which such Purchased Assets are
subject (other than Permitted Encumbrances), which releases shall
be effective at or prior to the Closing;
(viii) all
Records maintained with respect to the Business;
(ix) such
other bills of sale, assignments and other instruments of transfer
or conveyance as Buyer may reasonably request or as may be
otherwise necessary to evidence and effect the sale, assignment,
transfer, conveyance and delivery of the Purchased Assets to
Buyer;
(x) the
Additional Agreements duly executed by Seller; and
(xi) the
Net Working Capital Certificate.
REPRESENTATIONS AND WARRANTIES
OF SELLER
As an inducement
to Buyer to enter into this Agreement and to consummate the
transactions contemplated hereby, subject to the schedules prepared
by Seller relating to this Article 4 (the “
Schedules ”), Seller represents and warrants to Buyer
as follows:
4.1
Organization of Seller . Seller is a limited liability
company duly formed, validly existing and in good standing under
the laws of the State of California. Seller is duly qualified to
carry on the Business as now conducted and is in good standing in
each of the jurisdictions in which the ownership or leasing of the
Purchased Assets or the conduct of the Business requires such
qualification except where such failure to be so qualified or in
good standing would not result in a Material Adverse Event. Seller
has full corporate power and authority to own or lease and to
operate and use the Purchased Assets and to carry on the Business
as now conducted.
(a) Seller
has full power and authority to execute, deliver and perform this
Agreement and all of the Additional Agreements and to consummate
the transactions contemplated hereby and thereby. The execution,
delivery and performance of this Agreement and the Additional
Agreements by Seller have been duly and validly authorized and
approved by the Members. No other limited liability company
proceedings on the part of Seller are necessary to authorize the
consummation of the transactions contemplated by this Agreement and
the Additional Agreements. This Agreement has been, and the
Additional Agreements, upon execution and delivery by Seller, will
be duly authorized, executed and delivered by Seller and
constitutes, or upon execution and delivery will constitute, as the
case may be, legal, valid and binding obligations of Seller
enforceable against Seller in accordance with their terms, except
(i)
12
as such
enforcement may be subject to bankruptcy, insolvency,
reorganization, moratorium or other similar laws now or hereafter
in effect relating to creditors’ rights, and (ii) as the
remedy of specific performance and injunctive and other forms of
equitable relief may be subject to equitable defenses and to the
discretion of the court before which any proceeding therefor may be
brought.
(b) Except
as set forth on Schedule 4.2 , neither the execution,
delivery and performance of this Agreement or any of the Additional
Agreements nor the consummation of any of the transactions
contemplated hereby or thereby nor compliance with or fulfillment
of the terms, conditions and provisions hereof or thereof will:
(i) violate, conflict with or result in the breach of any
provision of Seller’s operating agreement or any other
organizational documents of Seller, (ii) violate or conflict
with any Requirement of Laws or Governmental Order applicable to
Seller, (iii) violate, conflict with, result in a breach of
the terms, conditions or provisions of, or constitute a default, an
event of default or an event creating rights of acceleration,
termination or cancellation or a loss of rights under any agreement
listed (or required to be listed) on Schedule 4.9 , or
result in the creation or imposition of any Encumbrance upon any of
the Purchased Assets, or (iv) require the approval, consent,
authorization or act of, or the making by Seller of any
declaration, filing or registration with, any Person.
(a) All
Tax Returns that were required to be filed by, or with respect to,
Seller on or before the Closing Date have been filed on a timely
basis in accordance with the laws, regulations and administrative
requirements of the appropriate Governmental Body in all
jurisdictions in which such Tax Returns were required to be filed.
All such Tax Returns that have been filed were, when filed, and
continue to be, true, correct and complete.
(b) All
Taxes due and payable on or before the Closing Date that are either
(i) required to be shown on any Tax Return filed by, or with
respect to, Seller or (ii) which were not required to be shown
on any Tax Return but which were required to be paid by or with
respect to Seller, have been timely paid on or before the Closing
Date. All Taxes that Seller was required by law to withhold or
collect have been (in the case of those that were already required
to be withheld or collected) duly withheld or collected and, to the
extent required, have been (in the case of those that were already
required to be paid) paid to the appropriate Governmental Body.
There are no Encumbrances, and will be no Encumbrances on the
Closing Date, with respect to Taxes upon any of the Purchased
Assets. Any liability of Seller for Taxes not yet due and payable
has adequately been provided for by Seller on the Financials
(whether or not required to be disclosed under GAAP).
(c) There
is no action, dispute, suit, proceeding, investigation, assessment,
audit or claim now pending against, or with respect to, Seller in
respect of any Tax nor is any action, dispute, suit, procedure,
investigation, assessment, audit or claim for additional Tax
expected by Seller to be asserted by any Governmental Body. No
Governmental Body has proposed any adjustment with respect to any
action, dispute, suit, proceeding, investigation, assessment, audit
or claim against or with respect to Seller. All deficiencies
proposed (plus any interest, penalties and additions to Tax that
were or are proposed to be assessed thereon, if any) with respect
to Seller have been paid. There are no outstanding waiver or
extensions of any
13
statute of
limitations relating to either the filing of any Tax Return or the
payment of any Tax for which Seller may be liable and no
Governmental Body has either formally or informally requested such
a waiver or extension.
(d) No
claim has ever been made by any Governmental Body in any
jurisdiction in which no Tax Return is filed by, or with respect
to, Seller that Seller may be subject to taxation by that
jurisdiction.
(e) Seller
has never been included in a consolidated, combined or unitary Tax
Return nor has Seller ever been a party to any tax sharing or
similar agreement or arrangement.
(f) Seller
does not have any liability (whether contingent or otherwise) for
Taxes of any other Person (i) under Treasury Regulations
Section 1.1502-6 (or any successor provision thereto or any
similar provision under state, local or foreign law); (ii) as
a successor or transferee or (iii) by contract (whether
written or unwritten).
(g) Seller
is a limited liability company treated as a partnership for income
Tax purposes for all years of its existence and has not elected at
any time to be taxed as a corporation in any
jurisdiction.
(h) No
property owned by Seller is property that Buyer or Seller will be
required to treat as being owned by another person pursuant to the
provisions of Section 168(f)(8) of the Internal Revenue Code
of 1954, as amended and in effect immediately before the enactment
of the Tax Reform Act of 1986, or is “tax-exempt use
property” within the meaning of Section 168(h)(1) of the
Code.
(i) Seller
is neither subject to an adjustment under Section 481 of the
Code nor has been required by, nor has requested or received the
permission of, any Governmental Body to change its methods of
accounting.
(j) Seller
is not a foreign person within the meaning of Section 1445 of
the Code.
(k) Seller
does not have in effect any tax elections for Federal income tax
purposes under Sections 108, 168, 338, 441, 471, 1017, 1033 or
4977 of the Code.
(l) There
is no contract, agreement, plan or arrangement covering any Person
that, individually or collectively, could give rise to the payment
of any amount that would not be deductible by Buyer or Seller by
reason of Sections 162(m) or 280G of the Code or as excessive or
unreasonable compensation.
(m) Seller
is not a party (other than as an investor) to any industrial
development bond.
(n) Seller
has never engaged in any exchange under which the gain realized on
such exchange was not recognized due to Section 1031 of the
Code.
14
4.4 Condition
and Sufficiency of Assets . The Purchased Assets are suitable
for the uses to which they are being put or have been put in the
ordinary course of business of the Business, and (ii) the
Purchased Assets constitute all of the assets necessary to conduct
the Business as currently conducted, except for the Excluded
Assets.
4.5
Governmental Permits .
(a) Seller
owns, holds or possesses all licenses, franchises, permits,
privileges, immunities, approvals and other authorizations from all
Governmental Bodies which are necessary to entitle it to own or
lease, operate and use the Purchased Assets and to carry on and
conduct the Business as currently conducted (collectively, the
“ Governmental Permits ”). Complete and correct
copies of all of the Transferred Permits have heretofore been
delivered or will be delivered prior to the Closing Date to Buyer
by Seller.
(b) Except
as set forth on Schedule 4.5(b) : (i) Seller has
fulfilled and performed its obligations under each of the
Governmental Permits, and to its knowledge, no event has occurred
or condition or state of facts exists which constitutes or, after
notice or lapse of time or both, would constitute a breach or
default or violation under any such Governmental Permit or which
permits or, after notice or lapse of time or both, would permit
revocation or termination of any such Governmental Permit, or which
might adversely affect in any material respect the rights of Seller
under any such Governmental Permit; (ii) no notice of
cancellation, of default, of violation or of any material dispute
concerning any Governmental Permit, or of any event, condition or
state of facts described in the preceding clause, has been received
by, or is known to, Seller; and (iii) each of the Transferred
Permits is valid, subsisting and in full force and effect, and may,
subject to applicable law, be assigned and transferred to Buyer in
accordance with this Agreement, and will continue in full force and
effect thereafter, in each case without (A) the occurrence of
any breach, default or forfeiture of rights thereunder, or
(B) the consent, approval or act of, or the making of any
filing with, any Governmental Body.
4.6 Title to
Purchased Assets . Seller has good, marketable and insurable
title to all of the Purchased Assets, free and clear of all
Encumbrances, except for Permitted Encumbrances and those
Encumbrances that will be removed at the Closing. The Purchased
Assets are not subject to any liability or obligation of whatever
nature, whether known or unknown, absolute, accrued, contingent or
otherwise. Upon delivery to Buyer on the Closing Date of the
instruments of transfer contemplated by Section 3.1(c) above,
Seller will thereby transfer to Buyer good, marketable and
insurable title to the Purchased Assets, free and clear of
Encumbrances other than Permitted Encumbrances.
4.7
Intellectual Property .
(a)
Schedule 4.7(a) sets forth the following:
(i) a
complete list of all Patents, Trademarks and Copyrights, and any
applications therefor in respect of any of the foregoing, included
in the Intellectual Property, which specifies, where applicable,
the jurisdictions in which such Intellectual Property right has
been issued or registered or in which an application for such
issuance and registration has been filed, including the respective
registration or application numbers and the names of all
registered
15
owners. All
registered Patents, Trademarks and Copyrights included in the
Intellectual Property and held by Seller are valid and
subsisting;
(ii) all
licenses, sublicenses and other agreements as to which Seller is a
party and pursuant to which Seller is authorized to use any
Intellectual Property belonging to any third party (
provided , however , that Seller need not list
object code end-user licenses granted to end-users in the ordinary
course of business that permit use of software products without a
right to modify, distribute or sublicense the same), including the
identity of all parties thereto, a description of the nature and
subject matter thereof, the applicable royalty and the term
thereof; and
(iii) all
licenses, sublicenses and ot
|